These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 37831477)

  • 1. Amino acid 17 in QRDR of Gyrase A plays a key role in fluoroquinolones susceptibility in mycobacteria.
    Wang S; Zhang J; Hameed HMA; Ding J; Guan P; Fang X; Peng J; Su B; Ma S; Tan Y; M Cook G; Zhang G; Lin Y; Zhong N; Hu J; Liu J; Zhang T
    Microbiol Spectr; 2023 Dec; 11(6):e0280923. PubMed ID: 37831477
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterization of DNA Gyrase Activity and Elucidation of the Impact of Amino Acid Substitution in GyrA on Fluoroquinolone Resistance in Mycobacterium avium.
    Thapa J; Chizimu JY; Kitamura S; Akapelwa ML; Suwanthada P; Miura N; Toyting J; Nishimura T; Hasegawa N; Nishiuchi Y; Gordon SV; Nakajima C; Suzuki Y
    Microbiol Spectr; 2023 Jun; 11(3):e0508822. PubMed ID: 37067420
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Extending the definition of the GyrB quinolone resistance-determining region in Mycobacterium tuberculosis DNA gyrase for assessing fluoroquinolone resistance in M. tuberculosis.
    Pantel A; Petrella S; Veziris N; Brossier F; Bastian S; Jarlier V; Mayer C; Aubry A
    Antimicrob Agents Chemother; 2012 Apr; 56(4):1990-6. PubMed ID: 22290942
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular characterization of fluoroquinolone-resistant Mycobacterium tuberculosis clinical isolates from Shanghai, China.
    Zhu C; Zhang Y; Shen Y; Siu GK; Wu W; Qian X; Deng G; Xu Y; Lau R; Fan X; Zhang W; Lu H; Yam WC
    Diagn Microbiol Infect Dis; 2012 Jul; 73(3):260-3. PubMed ID: 22560167
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular characterization of fluoroquinolone resistance in Mycobacterium tuberculosis: functional analysis of gyrA mutation at position 74.
    Lau RW; Ho PL; Kao RY; Yew WW; Lau TC; Cheng VC; Yuen KY; Tsui SK; Chen X; Yam WC
    Antimicrob Agents Chemother; 2011 Feb; 55(2):608-14. PubMed ID: 20956608
    [TBL] [Abstract][Full Text] [Related]  

  • 6. WQ-3810: A new fluoroquinolone with a high potential against fluoroquinolone-resistant Mycobacterium tuberculosis.
    Ouchi Y; Mukai T; Koide K; Yamaguchi T; Park JH; Kim H; Yokoyama K; Tamaru A; Gordon SV; Nakajima C; Suzuki Y
    Tuberculosis (Edinb); 2020 Jan; 120():101891. PubMed ID: 31778929
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of novel resistance-associated mutations and discrimination within whole-genome sequences of fluoroquinolone-resistant
    Chong Y; Li X; Long Y; Pei S; Ren Q; Feng F; Zhang H
    Microbiol Spectr; 2024 Jun; 12(6):e0393023. PubMed ID: 38687077
    [TBL] [Abstract][Full Text] [Related]  

  • 8. DNA gyrase inhibition assays are necessary to demonstrate fluoroquinolone resistance secondary to gyrB mutations in Mycobacterium tuberculosis.
    Pantel A; Petrella S; Matrat S; Brossier F; Bastian S; Reitter D; Jarlier V; Mayer C; Aubry A
    Antimicrob Agents Chemother; 2011 Oct; 55(10):4524-9. PubMed ID: 21768507
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Description of compensatory gyrA mutations restoring fluoroquinolone susceptibility in Mycobacterium tuberculosis.
    Pantel A; Petrella S; Veziris N; Matrat S; Bouige A; Ferrand H; Sougakoff W; Mayer C; Aubry A
    J Antimicrob Chemother; 2016 Sep; 71(9):2428-31. PubMed ID: 27234461
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High proportion of fluoroquinolone-resistant Mycobacterium tuberculosis isolates with novel gyrase polymorphisms and a gyrA region associated with fluoroquinolone susceptibility.
    Devasia R; Blackman A; Eden S; Li H; Maruri F; Shintani A; Alexander C; Kaiga A; Stratton CW; Warkentin J; Tang YW; Sterling TR
    J Clin Microbiol; 2012 Apr; 50(4):1390-6. PubMed ID: 22189117
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mutations in the gyrA and gyrB genes of fluoroquinolone-resistant Mycobacterium tuberculosis from TB patients in Thailand.
    Pitaksajjakul P; Wongwit W; Punprasit W; Eampokalap B; Peacock S; Ramasoota P
    Southeast Asian J Trop Med Public Health; 2005; 36 Suppl 4():228-37. PubMed ID: 16438215
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevalence of gyrA and B gene mutations in fluoroquinolone-resistant and -sensitive clinical isolates of Mycobacterium tuberculosis and their relationship with MIC of ofloxacin.
    Singh P; Jain A; Dixit P; Prakash S; Jaiswal I; Venkatesh V; Singh M
    J Antibiot (Tokyo); 2015 Jan; 68(1):63-6. PubMed ID: 25052485
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Molecular Genetics of Fluoroquinolone Resistance in Mycobacterium tuberculosis.
    Mayer C; Takiff H
    Microbiol Spectr; 2014 Aug; 2(4):MGM2-0009-2013. PubMed ID: 26104201
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A systematic review of Mycobacterium leprae DNA gyrase mutations and their impact on fluoroquinolone resistance.
    Chauffour A; Morel F; Reibel F; Petrella S; Mayer C; Cambau E; Aubry A
    Clin Microbiol Infect; 2021 Nov; 27(11):1601-1612. PubMed ID: 34265461
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sensitivities of ciprofloxacin-resistant Mycobacterium tuberculosis clinical isolates to fluoroquinolones: role of mutant DNA gyrase subunits in drug resistance.
    Suzuki Y; Nakajima C; Tamaru A; Kim H; Matsuba T; Saito H
    Int J Antimicrob Agents; 2012 May; 39(5):435-9. PubMed ID: 22421328
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fluoroquinolone interactions with Mycobacterium tuberculosis gyrase: Enhancing drug activity against wild-type and resistant gyrase.
    Aldred KJ; Blower TR; Kerns RJ; Berger JM; Osheroff N
    Proc Natl Acad Sci U S A; 2016 Feb; 113(7):E839-46. PubMed ID: 26792518
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A rapid and non-pathogenic assay for association of Mycobacterium tuberculosis gyrBA mutations and fluoroquinolone resistance using recombinant Mycobacterium smegmatis.
    Yoshida M; Nakata N; Miyamoto Y; Fukano H; Ato M; Hoshino Y
    FEMS Microbiol Lett; 2018 Dec; 365(23):. PubMed ID: 30418577
    [TBL] [Abstract][Full Text] [Related]  

  • 18. New insights into fluoroquinolone resistance in Mycobacterium tuberculosis: functional genetic analysis of gyrA and gyrB mutations.
    Malik S; Willby M; Sikes D; Tsodikov OV; Posey JE
    PLoS One; 2012; 7(6):e39754. PubMed ID: 22761889
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparative in vitro susceptibility of a novel fluoroquinolone antibiotic candidate WFQ-228, levofloxacin, and moxifloxacin against Mycobacterium tuberculosis.
    Qiao M; Ren W; Guo H; Huo F; Shang Y; Wang Y; Gao M; Pang Y
    Int J Infect Dis; 2021 May; 106():295-299. PubMed ID: 33864922
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of amino acid substitutions in B subunit of DNA gyrase in Mycobacterium leprae on fluoroquinolone resistance.
    Yokoyama K; Kim H; Mukai T; Matsuoka M; Nakajima C; Suzuki Y
    PLoS Negl Trop Dis; 2012; 6(10):e1838. PubMed ID: 23071850
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.